A dose ‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study

American Journal of Hematology, EarlyView.

Source: American Journal of Hematology - October 3, 2018 Category: Hematology Authors: Lewis L. Hsu, Sharada Sarnaik, Suzan Williams, Carl Amilon, Jenny Wissmar, Anders Berggren, on behalf of the HESTIA1 Investigators Source Type: research